Advanced search
Publication Cover
Patient Preference and Adherence Volume 10, 2016 - Issue
Submit an article Journal homepage
66
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Treatment satisfaction in cystic fibrosis: early patient experience with tobramycin inhalation powder

Jonathan Greenberg1 Division of Respiratory Diseases, Boston Children’s Hospital, Boston, MACorrespondence[email protected]
,
Jacqueline B Palmer2 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
,
Wing W Chan2 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
,
Catherine E Correia1 Division of Respiratory Diseases, Boston Children’s Hospital, Boston, MA
,
Diane Whalley3 RTI Health Solutions, Manchester, UK
,
Paul Shannon3 RTI Health Solutions, Manchester, UK
&
Gregory S Sawicki1 Division of Respiratory Diseases, Boston Children’s Hospital, Boston, MA
 show all
Pages 2163-2169 | Published online: 26 Oct 2016

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Stanley B. Fiel & Erica A. Roesch. (2022) The use of tobramycin for Pseudomonas aeruginosa: a review. Expert Review of Respiratory Medicine 16:5, pages 503-509.
Read now
Kamal Hamed, Valentino Conti, Hengfeng Tian & Emil Loefroth. (2017) Adherence to tobramycin inhaled powder vs inhaled solution in patients with cystic fibrosis: analysis of US insurance claims data. Patient Preference and Adherence 11, pages 831-838.
Read now

Articles from other publishers (7)

Christian Hügel, Christina Smaczny, Olaf Eickmeier, Stefan Zielen & Gernot Rohde. (2020) Zystische FibroseCystic fibrosis. Der Pneumologe 17:3, pages 223-233.
Crossref
Sawittree Sahakijpijarn, Hugh D.C. Smyth, Danforth P. Miller & Jeffry G. Weers. (2020) Post-inhalation cough with therapeutic aerosols: Formulation considerations. Advanced Drug Delivery Reviews 165-166, pages 127-141.
Crossref
Esther Noël, Bertrand Dussol, Didier Lacombe, Najya Bedreddine, Alain Fouilhoux, Pierre Ronco, Delphine Genevaz, Soumeya Bekri, Albert Hagège, Frédérique Dupuis-Siméon, Valérie Derrien Ansquer, Dominique P. Germain & Olivier Lidove. (2019) Treatment needs and expectations for Fabry disease in France: development of a new Patient Needs Questionnaire. Orphanet Journal of Rare Diseases 14:1.
Crossref
Francesco Blasi, Vincenzo Carnovale, Giuseppe Cimino, Vincenzina Lucidi, Donatello Salvatore, Barbara Messore, Marta Bartezaghi, Elisa Muscianisi & Pasquale Alberto Porpiglia. (2018) Treatment compliance in cystic fibrosis patients with chronic Pseudomonas aeruginosa infection treated with tobramycin inhalation powder: The FREE study. Respiratory Medicine 138, pages 88-94.
Crossref
Yasunori Uemura, Kenji Hagiwara & Katsuya Kobayashi. (2017) The intratracheal administration of locked nucleic acid containing antisense oligonucleotides induced gene silencing and an immune-stimulatory effect in the murine lung. PLOS ONE 12:11, pages e0187286.
Crossref
Kamal Hamed & Laurie Debonnett. (2017) Tobramycin inhalation powder for the treatment of pulmonary Pseudomonas aeruginosa infection in patients with cystic fibrosis: a review based on clinical evidence . Therapeutic Advances in Respiratory Disease 11:5, pages 193-209.
Crossref
Felix C. Ringshausen, James D. Chalmers & Mathias W. Pletz. 2017. Anti-infectives and the Lung. Anti-infectives and the Lung 57 79 .

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.